Skip to main
SEM
SEM logo

SEM Stock Forecast & Price Target

SEM Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Select Medical Holdings Corp is positioned favorably due to the anticipated expansion of margins in its Critical Illness Recovery Hospitals (CIRH) segment, driven by successful navigation of the CMS high-cost outlier threshold and stronger-than-expected performance in Inpatient Rehabilitation Facilities (IRF). The company's management projects an occupancy recovery to over 85% for the remainder of the year, indicating a solid demand for its services amid ongoing hospital ramp-up. Additionally, IRF revenue has demonstrated robust growth of 15.7%, fueled by both an increase in patient days and a rise in revenue per patient day, which further underscores the company’s positive financial trajectory.

Bears say

Select Medical Holdings Corp experienced a notable decline in its stock, dropping over 20% following the release of weaker first-quarter results and a modest reduction in guidance, primarily attributed to margin pressures within its Critical Illness Recovery Hospitals segment due to high-cost outlier thresholds. Additionally, the company reported a year-over-year decrease of 1.8% in revenue per patient day, further indicating challenges in its revenue generation. Occupancy rates also declined by 500 basis points to 82%, significantly influenced by the recent opening of new hospitals, which contributed to an overall decline in operational efficiency.

SEM has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Select Medical Holdings Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Select Medical Holdings Corporation (SEM) Forecast

Analysts have given SEM a Buy based on their latest research and market trends.

According to 4 analysts, SEM has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Select Medical Holdings Corporation (SEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.